CYTOKINE EXPRESSION IN THREE MOUSE MODELS OF EXPERIMENTAL HEPATITIS

Tiegs, 1992, A T-cell dependent experimental liver injury in mice inducible by concanavalin A, J Clin Invest, 90, 196, 10.1172/JCI115836

Schümann, 1999, Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins (Review), Toxicology, 138, 103, 10.1016/S0300-483X(99)00087-6

Bohlinger, 1996, DNA fragmentation in mouse organs during endotoxic shock, Am J Pathol, 149, 1381

Koziel, 1999, Cytokines in viral hepatitis, Semin Liver Dis, 19, 157, 10.1055/s-2007-1007107

McFarlane, 1999, Pathogenesis of autoimmune hepatitis, Biomed Pharmacother, 53, 255, 10.1016/S0753-3322(99)80096-1

Mizuhara, 1994, T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6, J Exp Med, 179, 1529, 10.1084/jem.179.5.1529

Gantner, 1995, Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor, Hepatology, 21, 190

Küsters, 1996, Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A, Gastroenterology, 111, 462, 10.1053/gast.1996.v111.pm8690213

Mizuhara, 1996, Critical involvement of interferon γ in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis, Hepatology, 23, 1608

Nicoletti, 2000, Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism, Hepatology, 32, 728, 10.1053/jhep.2000.17701

Louis, 1997, Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice, Hepatology, 25, 1382, 10.1002/hep.510250614

Freudenberg, 1986, Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin, Infect Immun, 51, 891, 10.1128/IAI.51.3.891-895.1986

Wright, 1990, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431, 10.1126/science.1698311

Car, 1994, Interferon gamma receptor deficient mice are resistant to endotoxic shock, J Exp Med, 179, 1437, 10.1084/jem.179.5.1437

Nagaki, 1999, Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice, J Hepatol, 31, 815, 10.1016/S0168-8278(99)80282-7

Wang, 1999, Identification of HMG-1 as a late mediator of endotoxin lethality in mice, Science, 285, 248, 10.1126/science.285.5425.248

Abraham, 2000, Cutting edge: HMG-1 as a mediator of acute lung inflammation, J Immunol, 165, 2950, 10.4049/jimmunol.165.6.2950

Andersson, 2000, High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes, J Exp Med, 192, 565, 10.1084/jem.192.4.565

Bendelac, 1997, Mouse CD1-specific NK1 T cells: development, specificity, and function, Annu Rev Immunol, 15, 535, 10.1146/annurev.immunol.15.1.535

Toyabe, 1997, Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice, J Immunol, 159, 1537, 10.4049/jimmunol.159.3.1537

Kaneko, 2000, Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis, J Exp Med, 191, 105, 10.1084/jem.191.1.105

Gallay, 1994, Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice, Proc Natl Acad Sci USA, 91, 7922, 10.1073/pnas.91.17.7922

Ulevitch, 1995, Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin, Annu Rev Immunol, 13, 437, 10.1146/annurev.iy.13.040195.002253

Bergmeyer, 1984

Schümann, 2000, Importance of Kupffer cells for T cell-dependent liver injury in mice, Am J Pathol, 157, 1671, 10.1016/S0002-9440(10)64804-3

Ehlers, 1992, Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity, J Immunol, 149, 3016, 10.4049/jimmunol.149.9.3016